On Invalid Date, Voyager Therapeutics (NASDAQ: VYGR) reported Q3 2023 earnings per share (EPS) of -$0.59, up 228.26% year over year. Total Voyager Therapeutics earnings for the quarter were -$25.90 million. In the same quarter last year, Voyager Therapeutics's earnings per share (EPS) was $0.46.
As of Q4 2023, Voyager Therapeutics's earnings has grown year over year. Voyager Therapeutics's earnings in the past year totalled $52.31 million.
What was VYGR's revenue last quarter?
On Invalid Date, Voyager Therapeutics (NASDAQ: VYGR) reported Q3 2023 revenue of $4.61 million up 88.77% year over year. In the same quarter last year, Voyager Therapeutics's revenue was $41.09 million.
What was VYGR's revenue growth in the past year?
As of Q4 2023, Voyager Therapeutics's revenue has grown 124.58% year over year. This is 12.58 percentage points higher than the US Biotechnology industry revenue growth rate of 112.01%. Voyager Therapeutics's revenue in the past year totalled $158.40 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.